MX2017009998A - Biomarcadores para cancer pancreatico. - Google Patents
Biomarcadores para cancer pancreatico.Info
- Publication number
- MX2017009998A MX2017009998A MX2017009998A MX2017009998A MX2017009998A MX 2017009998 A MX2017009998 A MX 2017009998A MX 2017009998 A MX2017009998 A MX 2017009998A MX 2017009998 A MX2017009998 A MX 2017009998A MX 2017009998 A MX2017009998 A MX 2017009998A
- Authority
- MX
- Mexico
- Prior art keywords
- biomarkers
- pancreatic cancer
- diagnosis
- treatment
- present
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title abstract 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 title abstract 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 title 1
- 201000002528 pancreatic cancer Diseases 0.000 title 1
- 208000008443 pancreatic carcinoma Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 2
- 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 abstract 2
- 102100023882 Endoribonuclease ZC3H12A Human genes 0.000 abstract 1
- 101710112715 Endoribonuclease ZC3H12A Proteins 0.000 abstract 1
- 101001054921 Homo sapiens Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 abstract 1
- 102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 abstract 1
- 108010088412 Trefoil Factor-1 Proteins 0.000 abstract 1
- 102000008817 Trefoil Factor-1 Human genes 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- QGVYYLZOAMMKAH-UHFFFAOYSA-N pegnivacogin Chemical compound COCCOC(=O)NCCCCC(NC(=O)OCCOC)C(=O)NCCCCCCOP(=O)(O)O QGVYYLZOAMMKAH-UHFFFAOYSA-N 0.000 abstract 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Data Mining & Analysis (AREA)
- Organic Chemistry (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1501930.0A GB201501930D0 (en) | 2015-02-05 | 2015-02-05 | Biomarkers for pancreatic cancer |
| PCT/GB2016/050277 WO2016124947A1 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017009998A true MX2017009998A (es) | 2018-02-01 |
Family
ID=52746188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017009998A MX2017009998A (es) | 2015-02-05 | 2016-02-05 | Biomarcadores para cancer pancreatico. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10782301B2 (enExample) |
| EP (2) | EP4458849A3 (enExample) |
| JP (1) | JP6786499B2 (enExample) |
| KR (1) | KR102569984B1 (enExample) |
| CN (1) | CN107533062B (enExample) |
| AU (1) | AU2016214140B2 (enExample) |
| BR (1) | BR112017016808A2 (enExample) |
| CA (1) | CA2974775C (enExample) |
| CL (1) | CL2017001972A1 (enExample) |
| GB (1) | GB201501930D0 (enExample) |
| HK (1) | HK1247276A1 (enExample) |
| IL (1) | IL253710B (enExample) |
| MX (1) | MX2017009998A (enExample) |
| SG (1) | SG11201706223VA (enExample) |
| WO (1) | WO2016124947A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10782301B2 (en) | 2015-02-05 | 2020-09-22 | Queen Mary University Of London | Biomarkers for pancreatic cancer |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2442919T3 (es) | 2007-03-27 | 2014-02-14 | Immunovia Ab | Firma/marcadores de proteínas para la detección de adenocarcinoma |
| GB201517028D0 (en) * | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
| CN107674884A (zh) * | 2017-09-05 | 2018-02-09 | 上海速创诊断产品有限公司 | 一种用于检测胰腺癌标记物reg1a的生物素化脂质体及其制备方法和应用 |
| US20210052231A1 (en) * | 2017-12-14 | 2021-02-25 | Salcit Technologies Private Limited | Method and system for analyzing risk associated with respiratory sounds |
| TWI643869B (zh) * | 2017-12-14 | 2018-12-11 | 國立高雄大學 | Molecular extension printing material and preparation method thereof, magnetic molecular extension printing material and preparation method thereof |
| KR102000387B1 (ko) * | 2018-02-13 | 2019-07-15 | 서울대학교산학협력단 | 췌관내유두상점액종양의 악성도를 감별할 수 있는 단백질 바이오마커 및 그 용도 |
| CN109358055A (zh) * | 2018-12-18 | 2019-02-19 | 沈阳理工大学 | 增敏测定空气中氨的混合指示剂试纸及其制备和检测方法 |
| CN111303281A (zh) * | 2019-05-14 | 2020-06-19 | 长春恒晓生物科技有限责任公司 | 制备胰石蛋白抗体及建立检测psp方法 |
| EP4045912A1 (en) * | 2019-10-18 | 2022-08-24 | Reccan Diagnostics AB | Apparatuses and methods for detection of pancreatic cancer |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN113248609B (zh) * | 2021-07-14 | 2021-09-10 | 深圳市盛波尔生命科学技术有限责任公司 | 针对再生胰岛衍生蛋白1α的抗体组合以及包含其的检测试剂盒 |
| CN115290732B (zh) * | 2022-07-14 | 2025-02-25 | 西北大学 | 一种检测胰蛋白酶的电化学生物传感器及其制备方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| DE60325628D1 (de) | 2002-09-30 | 2009-02-12 | Oncotherapy Science Inc | Gene und polypeptide in verbindung mit menschlichen pankreaskarzinomen |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| US20050095611A1 (en) | 2003-05-02 | 2005-05-05 | Chan Daniel W. | Identification of biomarkers for detecting pancreatic cancer |
| CA2525740A1 (en) | 2003-05-15 | 2004-11-25 | Europroteome Ag | Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer |
| DE102004042822A1 (de) | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen |
| CA2595377A1 (en) | 2005-01-28 | 2006-08-03 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
| US20070031867A1 (en) | 2005-06-27 | 2007-02-08 | John Wayne Cancer Institute | Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome |
| US20070077582A1 (en) | 2005-09-16 | 2007-04-05 | Primera Biosystems, Inc. | Method for quantitative detection of short RNA molecules |
| CN101384273B (zh) | 2006-01-05 | 2013-07-10 | 俄亥俄州立大学研究基金会 | 胰腺内分泌和腺泡肿瘤中的微小rna表达异常 |
| EP2375254A1 (en) | 2006-02-17 | 2011-10-12 | The Children's Medical Center Corporation | Free NGAL as a biomarker for cancer |
| US20070231822A1 (en) | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| WO2008036765A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| EP2084539A4 (en) | 2006-10-03 | 2010-09-08 | Neuren Pharmaceuticals Ltd | TREFOIL FACTORS BINDING CONFORMATION-SPECIFIC ANTIBODIES AND METHODS FOR TREATING CANCER DISEASES AND PROLIFERATION DISORDERS THEREWITH |
| US20100092476A1 (en) | 2006-11-17 | 2010-04-15 | Hanash Samir M | Pancreatic cancer biomarkers |
| CN104195226B (zh) | 2007-04-30 | 2017-01-11 | 俄亥俄州立大学研究基金会 | 用于区分胰腺癌与正常胰腺功能和/或慢性胰腺炎的方法 |
| EP2568053B1 (en) | 2008-05-12 | 2014-04-16 | Genomic Health, Inc. | Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| WO2009147530A2 (en) | 2008-06-06 | 2009-12-10 | Neuren Pharmaceuticals Ltd | Conformation specific antibodies that bind trefoil factors |
| JP2012100536A (ja) * | 2009-03-02 | 2012-05-31 | Genescience Co Ltd | 血液試料に含まれる単核球細胞を用いた癌関連遺伝子の発現解析による癌の遺伝子検査方法 |
| CN102725000B (zh) | 2010-01-19 | 2015-10-07 | 免疫医疗公司 | 靶向胰岛素-样生长因子i型受体(igf-1r)的新型单特异性和双特异性人源化抗体 |
| EP2415877A3 (en) * | 2010-02-17 | 2012-02-15 | Deutsches Krebsforschungszentrum | Means and methods for diagnosing pancreatic cancer |
| WO2011137288A2 (en) | 2010-04-30 | 2011-11-03 | The Ohio State University | Mirna networks in cancers and leukemias and uses thereof |
| WO2012100339A1 (en) | 2011-01-27 | 2012-08-02 | University Health Network | Methods and compositions for the detection of pancreatic cancer |
| WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
| WO2013043644A1 (en) | 2011-09-21 | 2013-03-28 | The University Of North Carolina At Chapel Hill | Methods using liver disease biomarkers |
| DE102012204366B4 (de) | 2011-12-16 | 2017-07-27 | Siemens Aktiengesellschaft | Verfahren und Kit zur Identifizierung und Quantifizierung von einer einzelsträngigen Ziel-Nukleinsäure |
| US20150018235A1 (en) | 2012-01-13 | 2015-01-15 | Oncocyte Corporation | Methods and Compositions for the Treatment and Diagnosis of Pancreatic Cancer |
| US20150011414A1 (en) | 2012-01-16 | 2015-01-08 | Herlev Hospital | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples |
| US20130216545A1 (en) | 2012-02-19 | 2013-08-22 | Claresa Levetan | Early Diagnosis and Novel Treatment of Cancer |
| WO2013152989A2 (en) | 2012-04-10 | 2013-10-17 | Eth Zurich | Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer |
| US20130317083A1 (en) | 2012-05-04 | 2013-11-28 | Thomas Jefferson University | Non-coding transcripts for determination of cellular states |
| WO2014062856A1 (en) * | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| US20140271621A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods of prognosis and diagnosis of pancreatic cancer |
| US20150018230A1 (en) | 2013-06-11 | 2015-01-15 | Indiana University Research And Technology Corp. | PLASMA miRNA SIGNATURE FOR THE ACCURATE DIAGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA |
| GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
| GB201517028D0 (en) | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
-
2015
- 2015-02-05 GB GBGB1501930.0A patent/GB201501930D0/en not_active Ceased
-
2016
- 2016-02-05 EP EP24188089.7A patent/EP4458849A3/en active Pending
- 2016-02-05 CN CN201680018784.8A patent/CN107533062B/zh active Active
- 2016-02-05 MX MX2017009998A patent/MX2017009998A/es unknown
- 2016-02-05 KR KR1020177024461A patent/KR102569984B1/ko active Active
- 2016-02-05 EP EP16703840.5A patent/EP3254111A1/en active Pending
- 2016-02-05 HK HK18106404.7A patent/HK1247276A1/zh unknown
- 2016-02-05 AU AU2016214140A patent/AU2016214140B2/en active Active
- 2016-02-05 WO PCT/GB2016/050277 patent/WO2016124947A1/en not_active Ceased
- 2016-02-05 US US15/548,240 patent/US10782301B2/en active Active
- 2016-02-05 JP JP2017541693A patent/JP6786499B2/ja active Active
- 2016-02-05 SG SG11201706223VA patent/SG11201706223VA/en unknown
- 2016-02-05 BR BR112017016808A patent/BR112017016808A2/pt not_active Application Discontinuation
- 2016-02-05 CA CA2974775A patent/CA2974775C/en active Active
-
2017
- 2017-07-28 IL IL253710A patent/IL253710B/en active IP Right Grant
- 2017-08-02 CL CL2017001972A patent/CL2017001972A1/es unknown
-
2020
- 2020-08-26 US US17/003,139 patent/US11977077B2/en active Active
-
2024
- 2024-04-02 US US18/624,620 patent/US20250251399A1/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10782301B2 (en) | 2015-02-05 | 2020-09-22 | Queen Mary University Of London | Biomarkers for pancreatic cancer |
| US11977077B2 (en) | 2015-02-05 | 2024-05-07 | Queen Mary University Of London | Biomarkers for pancreatic cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201706223VA (en) | 2017-08-30 |
| US20250251399A1 (en) | 2025-08-07 |
| US10782301B2 (en) | 2020-09-22 |
| EP3254111A1 (en) | 2017-12-13 |
| GB201501930D0 (en) | 2015-03-25 |
| CA2974775C (en) | 2023-11-07 |
| AU2016214140B2 (en) | 2021-11-04 |
| CL2017001972A1 (es) | 2018-03-23 |
| US20190204323A1 (en) | 2019-07-04 |
| KR102569984B1 (ko) | 2023-08-22 |
| AU2016214140A1 (en) | 2017-08-17 |
| EP4458849A3 (en) | 2024-12-04 |
| CA2974775A1 (en) | 2016-08-11 |
| BR112017016808A2 (pt) | 2018-04-03 |
| KR20170129118A (ko) | 2017-11-24 |
| IL253710B (en) | 2020-08-31 |
| CN107533062B (zh) | 2021-03-23 |
| US20220042998A1 (en) | 2022-02-10 |
| US11977077B2 (en) | 2024-05-07 |
| EP4458849A2 (en) | 2024-11-06 |
| WO2016124947A1 (en) | 2016-08-11 |
| JP6786499B2 (ja) | 2020-11-18 |
| HK1247276A1 (zh) | 2018-09-21 |
| JP2018504609A (ja) | 2018-02-15 |
| IL253710A0 (en) | 2017-09-28 |
| CN107533062A (zh) | 2018-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017009998A (es) | Biomarcadores para cancer pancreatico. | |
| MY197809A (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
| MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
| EP3839510A3 (en) | Blood-based biomarkers of tumor sensitivity to pd-1 antagonists | |
| MX2021006510A (es) | Nanomotores impulsados por enzimas funcionalizados. | |
| MX2017008421A (es) | Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga. | |
| MX2016012285A (es) | Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf. | |
| WO2013107459A3 (en) | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples | |
| HK1246828A1 (zh) | 用於检测癌症的生物标志物组 | |
| MX373957B (es) | Un método in vitro para detectar un biomarcador de cáncer en un sujeto. | |
| HK1214652A1 (zh) | 用於检测胰腺癌的方法和组合物 | |
| WO2015171736A3 (en) | Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma | |
| MX2013014153A (es) | Biomarcadores paa terapia de inhibidor de hedgehog. | |
| NZ589063A (en) | Detection and treatment of pancreatic, ovarian and other cancers using antibodies that specifically bind to denatured CD70 | |
| MX2014009751A (es) | Anticuerpos contra integrina alfavhbeta6 y uso de los mismos para tratar cancer. | |
| MX340453B (es) | Biomarcadores para cancer de pulmon. | |
| EP3606507A4 (en) | SEROLOGICAL BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG CANCER | |
| ZA202205916B (en) | Use of cell free nucleosomes as biomarkers | |
| WO2015073896A3 (en) | Biomarkers for psma targeted therapy for prostate cancer | |
| MX357429B (es) | Predictores para el tratamiento del cáncer. | |
| WO2015091575A3 (en) | Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer | |
| IL284827A (en) | A biomarker panel for the diagnosis and prognosis of cancer | |
| MX2013011431A (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
| CA3194356C (en) | Compositions and methods for detecting and treating ovarian cancer | |
| NZ729773A (en) | Biomarkers for disease progression in melanoma |